Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.69 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | TLR2 | O60603 | 2/20 | 0.41 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | NAMPT | P43490 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8036869 | 0.96 | KMT2A (0.64) | KMT2AEPHX2TLR2TLR1 | |
| SCHEMBL3087950 | 0.91 | KMT2A (0.58) | KMT2AEPHX2CASP3 | |
| SCHEMBL20759696 | 0.87 | KMT2A (0.78) | KMT2AEPHX2TLR2TLR1CASP3 | |
| SCHEMBL25390706 | 0.85 | KMT2A (0.52) | KMT2AEPHX2TLR2TLR1CASP3 | |
| SCHEMBL30748702 | 0.85 | KMT2A (0.52) | KMT2AEPHX2TLR2TLR1CASP3 | |
| SCHEMBL25391589 | 0.85 | KMT2A (0.52) | KMT2AEPHX2TLR2TLR1CASP3 | |
| SCHEMBL16942065 | 0.85 | KMT2A (0.52) | KMT2AEPHX2TLR2TLR1CASP3 | |
| SCHEMBL22442468 | 0.85 | KMT2A (0.80) | KMT2AEPHX2TLR2TLR1CASP3 | |
| SCHEMBL20758998 | 0.84 | KMT2A (0.74) | KMT2AEPHX2NAMPT | |
| SCHEMBL3060297 | 0.84 | KMT2A (0.51) | KMT2AEPHX2CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12265082-B2 | Detecting microbial infection in wounds | SYNOVO GMBH (DE) | 2025-04-01 | — | — | US | disclosed |
| US-20240027454-A1 | DETECTING MICROBIAL INFECTION IN WOUNDS | SYNOVO GMBH (DE) | 2024-01-25 | — | — | US | disclosed |
| US-11740241-B2 | Construct including an anchor, an enzyme recognition site and an indicator region for detecting microbial infection in wounds | SYNOVO GMBH (DE) | 2023-08-29 | — | — | US | disclosed |
| CN-109564213-B | Detecting microbial wound infection | 西诺福有限公司 | 2023-01-31 | — | — | CN | disclosed |
| US-20210088518-A1 | DETECTING MICROBIAL INFECTION IN WOUNDS | SYNOVO GMBH (DE) | 2021-03-25 | — | — | US | disclosed |
| EP-3436821-A2 | DETECTING MICROBIAL INFECTION IN WOUNDS | Synovo GmbH (DE) | 2019-02-06 | — | — | EP | disclosed |
| WO-2017212345-A2 | DETECTING MICROBIAL INFECTION IN WOUNDS | SYNOVO GMBH (DE) | 2017-12-14 | — | — | WO | disclosed |
| EP-0644890-B1 | OLIGONUCLEOTIDE-POLYAMIDE CONJUGATES | HOWARD FLOREY INST OF BR EX PH (AU) | 2001-12-05 | — | — | EP | disclosed |
| US-6232463-B1 | CROSSLINKING OLIGONUCLEOTIDES CONTAINING PURINE ANALOGS HAVING REACTIVE SITES ON THE NUCLEOBASE AND ON A SUGAR MOIETY; ANTISENSE AGENTS | ISIS PHARMACEUTICALS, INC. | 2001-05-15 | — | — | US | disclosed |
| EP-0383803-B1 | OLIGONUCLEOTIDE-POLYAMIDE CONJUGATES | HOWARD FLOREY INST OF (AU) | 2000-05-03 | — | — | EP | disclosed |
| US-5811534-A | PURINE-BASED COMPOUNDS FOR INCLUSION INTO OLIGONUCLEOTIDES | ISIS PHARMACEUTICALS, INC. (US) | 1998-09-22 | — | — | US | disclosed |
| US-5681941-A | GENETIC ENGINEERING; CROSSLINKING OLIGONUCLEOTIDES | ISIS PHARMACEUTICALS, INC. (US) | 1997-10-28 | — | — | US | disclosed |
| US-5677440-A | Oligonucleotide-polyamide conjugates | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 1997-10-14 | — | — | US | disclosed |
| US-5525465-A | Oligonucleotide-polyamide conjugates and methods of production and applications of the same | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 1996-06-11 | — | — | US | disclosed |
| EP-0644890-A4 | OLIGONUCLEOTIDE-POLYAMIDE CONJUGATES. | FLOREY HOWARD INST (AU) | 1996-03-27 | — | — | EP | disclosed |
| EP-0644890-A1 | OLIGONUCLEOTIDE-POLYAMIDE CONJUGATES | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 1995-03-29 | — | — | EP | disclosed |
| WO-1993024511-A1 | OLIGONUCLEOTIDE-POLYAMIDE CONJUGATES | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 1993-12-09 | — | — | WO | disclosed |
| EP-0383803-A4 | OLIGONUCLEOTIDE-POLYAMIDE CONJUGATES | — | 1991-03-20 | — | — | EP | disclosed |
| EP-0383803-A1 | OLIGONUCLEOTIDE-POLYAMIDE CONJUGATES | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 1990-08-29 | — | — | EP | disclosed |
| WO-1989003849-A1 | OLIGONUCLEOTIDE-POLYAMIDE CONJUGATES | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY (AU) | 1989-05-05 | — | — | WO | disclosed |